POST-OPERATIVE ADJUVANT CHEMOTHERAPY WITH FLUOROURACIL, DOXORUBICIN, CYCLOPHOSPHAMIDE, AND BCG VACCINE - FOLLOW-UP REPORT

被引：43
作者：
BUZDAR, AU
BLUMENSCHEIN, GR
GUTTERMAN, JU
TASHIMA, CK
HORTOBAGYI, GN
SMITH, TL
CAMPOS, LT
WHEELER, WL
HERSH, EM
FREIREICH, EJ
GEHAN, EA
机构：
[1] UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,CTR CANC,DEPT DEV THERAPEUT,HOUSTON,TX 77030
[2] UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,CTR CANC,DEPT BIOMATH,HOUSTON,TX 77030
来源：
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 1979年 / 242卷 / 14期
关键词：
D O I：
10.1001/jama.242.14.1509
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1509 / 1513
页数：5
相关论文
共 16 条
  • [1] AHMANN DL, 1978, LANCET, V1, P893
  • [2] BLUMENSCHEIN GR, 1974, MAR P AM SOC CLIN ON, P193
  • [3] BONADONNA G, 1977, CANCER-AM CANCER SOC, V39, P2904, DOI 10.1002/1097-0142(197706)39:6<2904::AID-CNCR2820390677>3.0.CO
  • [4] 2-8
  • [5] BUZDAR AU, 1978, CANCER, V41, P1064, DOI 10.1002/1097-0142(197803)41:3<1064::AID-CNCR2820410340>3.0.CO
  • [6] 2-Q
  • [7] COX DR, 1972, J R STAT SOC B, V34, P187
  • [8] EWY GA, 1978, CANCER TREAT REP, V62, P915
  • [9] FISHER B, 1977, CANCER-AM CANCER SOC, V39, P2883, DOI 10.1002/1097-0142(197706)39:6<2883::AID-CNCR2820390676>3.0.CO
  • [10] 2-9
12